# Percutaneous Revascularization in Infarction With Late Presentation and Absence of Viability: Effects on Left Ventricular Remodeling and Contractility

> **NCT05160311** · NA · UNKNOWN · sponsor: **Instituto Dante Pazzanese de Cardiologia** · enrollment: 70 (estimated)

## Conditions studied

- STEMI - ST Elevation Myocardial Infarction
- Myocardial Dysfunction
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Optimized Medical Treatment (OMT)
- **DEVICE:** Drug Eluting Stent (DES) Coronary Angioplasty

## Key facts

- **NCT ID:** NCT05160311
- **Lead sponsor:** Instituto Dante Pazzanese de Cardiologia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05160311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05160311, "Percutaneous Revascularization in Infarction With Late Presentation and Absence of Viability: Effects on Left Ventricular Remodeling and Contractility". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05160311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*